Key facts
- It has raised $4.3M; the latest was Early Stage VC ($4.3M) in Jan 2026.
- Notable investors include Huihe Asset Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Muguang Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Muguang Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Muguang Medical
Manufacturer of high-precision medical imaging robots intended to enhance diagnostic accuracy and efficiency in clinical settings. The company offers integration of proprietary imaging technologies, compatibility with a wide range of clinical applications, and support for minimally invasive procedures, thereby enabling healthcare providers to enhance diagnostic accuracy, improve patient outcomes, and reduce reliance on imported medical technologies.
- Sector
- Information Technology
- HQ
- Chengdu, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Muguang Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Muguang Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Muguang Medical in its N-PORT filings yet. We sweep new filings monthly.